Tag: antares pharma

November 28, 2018

Antares’ Device Aids Teva’s Generic EpiPen Launch

The EpiPen and this generic equivalent are indicated for the emergency treatment of severe allergic reactions.
November 27, 2018

Antares Pharma Partner Teva Announces Commercial Availability of Generic Epipen

Antares Pharma (NASDAQ:ATRS) announced that Teva Pharmaceutical Industries generic EpiPen is now commercially available in limited quantities. As quoted in the...
October 1, 2018

Antares Receives FDA Approval of Xyosted (Testosterone Enanthate) Injection for Testosterone Replacement Therapy

Antares Pharma (NASDAQ:ATRS) today announced the approval of XYOSTED (testosterone enanthate) injection by the U.S. Food and Drug Administration (FDA)....
August 17, 2018

Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector

Antares Pharma (NASDAQ:ATRS) announced that the U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical, epinephrine auto injector drug-device...